Caroline Pothet is current head of advanced therapies (ad interim) at the European Medicines Agency since October 2022; Caroline has been working at the EMA since September 2020 initially as a Senior Regulatory Specialist, providing regulatory and scientific advice to EMA staff, Scientific Committees (including the Committee on Advanced Therapies) and external stakeholders during the development, evaluation and surveillance of oncology medicinal products and Advanced Therapies. Prior to joining the Agency, Caroline worked in the Pharmaceutical Industry holding various positions in Global R&D between 1998 and 2020, including 10 years in oncology and 7 years in immuno-inflammation therapeutic areas. Caroline is a pharmacist by training, and has a Master in Drug Development and International Regulatory Affairs.